RE:RE:RE:RE:RE:RE:RE:New base $2 The one significant point that is being missed is that with a marginal islet dose (which currently comes from cadavers), a single doner may be able to help a few patients who have the pouch. I think the Edmonton protocol might require 2 pacreata per patient. I still think the price will come down on news. Hype right now is huge and there are lots of people waiting to take profits. Once the selling starts it's going to be a tsunami of shares hitting the market imo.
MustangSalley wrote: Mouth,
You make a very valid point . Even with a single top up, insulin independence is wuite remarkable . How many patients would go for that ?
it is a significant milestone in itself.
If you look at the recent December presentation , take careful note that they are now manufacturing several sizes of the pouch according to Gmp specs. This is significant because it means they can implant varying sizes of pouches or more than mulch in a patient . This might give Witowski leeway so he can dose the appropriate number of islet cells on the pouch to achieve insulin independence . I believe they are close and there will be no top up . Just my intuition.
The thing that baffles me why they don't have the 7 th patient yet ? Perhaps Witioeski can answer some of these questions .
Keep up the great dialogue Mouth! Nice conversing on an intellectual level on this blog.
Ms Sally